Skip to main content
. Author manuscript; available in PMC: 2010 Feb 10.
Published in final edited form as: Circulation. 2009 Jan 26;119(5):663–670. doi: 10.1161/CIRCULATIONAHA.108.797035

Table 1.

Demographics and SCD risk factors in case and control subjects

Cases (n = 373) Controls (n = 309) p-value*
Age, y 70 ± 13 64 ± 12 <0.0001
Male, % 60 64 0.24
History of MI 33% 28% 0.23
History of diabetes 40% 33% 0.06
Obese 35% 38% 0.37
Severe LV Dysfunction (EF ≤ 35%) 22% 9% 0.004
Using medication with risk of causing Torsades de Pointes (qtdrugs.org List 1) 7.5% 3.9% 0.05
Using medication that may prolong QT interval (qtdrugs.org Lists 2 or 3) 38% 26% 0.0005
Any medication from Lists 1-3 43% 27% <0.0001
*

p-value from t-tests for continuous variables and chi-square tests for categorical variables.

BMI ≥30; BMI available for 309 cases and 291 controls

EF from echo, angiogram, or MUGA for 188 cases and 116 controls